Company
Sanofi Ventures
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Epicrispr Biotechnologies | Series C | 2026-08-11 | |
| Expedition Therapeutics | Series B | 2026-08-05 | |
| Nura Bio Inc | Series B | 2026-06-22 | |
| Memento Medicines | Series A | 2026-06-19 | |
| BranchLab | Series A | 2026-05-13 | |
| Diagonal Therapeutics | Series B | 2026-01-09 | Lead |
| Trial Library | Series A | 2025-12-02 | |
| Expedition Therapeutics | Series A | 2025-10-10 | Lead |
| Star Therapeutics | Series D | 2025-10-01 | Lead |
| Character Biosciences | Series B Extension | 2025-09-18 | |
| Attovia Therapeutics | Series C | 2025-04-16 | Lead |
| Glycomine | Series C | 2025-04-16 | |
| Latigo Biotherapeutics | Series B | 2025-03-17 | |
| Abcuro | Series C | 2025-02-13 | |
| Atalanta Therapeutics | Series B | 2025-01-28 | Lead |
| Normunity | Series B | 2025-01-13 | |
| Nuvig Therapeutics | Series B | 2024-12-05 | Lead |
| Sudo Biosciences | Series B | 2024-02-13 | |
| Sudo Biosciences | Series B | 2023-12-20 | |
| ReCode Therapeutics | Series B Financing | 2023-09-19 | |
| Abcuro | Series B Financing | 2023-08-18 | |
| Therini Bio | Series A Funding | 2023-04-27 | Lead |
| QurAlis | Series B Financing | 2023-03-09 | Lead |
| Matchpoint Therapeutics | Series A | 2022-10-17 | Lead |